These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9201568)

  • 1. An audit of discharge medication for secondary prophylaxis post-myocardial infarction.
    Richardson J; Truman C
    J Clin Pharm Ther; 1996 Dec; 21(6):413-6. PubMed ID: 9201568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Michaels AD; Maynard C; Every NR
    J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
    Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
    Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issues.
    Underwood P; Beck P
    Qual Saf Health Care; 2002 Sep; 11(3):230-2. PubMed ID: 12486986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in long-term management of survivors of acute myocardial infarction by cardiologists in a government university-affiliated teaching hospital.
    Mitra S; Findley K; Frohnapple D; Mehta JL
    Clin Cardiol; 2002 Jan; 25(1):16-8. PubMed ID: 11808833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of secondary prevention medication after myocardial infarction - the role of general practitioners and patients.
    Bally K; Buechel RR; Buser P; Tschudia P; Martinaa B; Zeller A
    Swiss Med Wkly; 2013; 143():w13896. PubMed ID: 24193548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of myocardial infarction therapy at a Canadian tertiary referral hospital.
    Leung M; Brown G; Webb J
    Can J Cardiol; 1995 Jan; 11(1):43-8. PubMed ID: 7850664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
    Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic therapies after myocardial infarction.
    Rapaport E; Gheorghiade M
    Am J Med; 1996 Oct; 101(4A):4A61S-69S; discussion 4A69S-70S. PubMed ID: 8900339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age on the use of evidence-based therapies for acute myocardial infarction.
    Tran CT; Laupacis A; Mamdani MM; Tu JV
    Am Heart J; 2004 Nov; 148(5):834-41. PubMed ID: 15523314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
    Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
    Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
    Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME; Bouvy ML; de Blaey CJ; de Boer A
    Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study.
    Lindhardsen J; Ahlehoff O; Gislason GH; Madsen OR; Olesen JB; Torp-Pedersen C; Hansen PR
    Ann Rheum Dis; 2012 Sep; 71(9):1496-501. PubMed ID: 22402144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of antiplatelet therapy in acute coronary syndromes and for secondary prevention following a myocardial infarction.
    Jafri SM; Zarowitz B; Goldstein S; Lesch M
    Prog Cardiovasc Dis; 1993; 36(1):75-83. PubMed ID: 8321905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines.
    Pandey A; Golwala H; Hall HM; Wang TY; Lu D; Xian Y; Chiswell K; Joynt KE; Goyal A; Das SR; Kumbhani D; Julien H; Fonarow GC; de Lemos JA
    JAMA Cardiol; 2017 Jul; 2(7):723-731. PubMed ID: 28445559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to guidelines for pharmacological treatment of young adults with myocardial infarction in Poland: Data from Polish Registry of Acute Coronary Syndromes (PL-ACS).
    Lisowska A; Makarewicz-Wujec M; Dworakowska AM; Kozłowska-Wojciechowska M
    J Clin Pharm Ther; 2019 Jun; 44(3):471-478. PubMed ID: 30763467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.